No Data
HHS Panel to Vote in Nov. on DMD Screening for Newborns
Boy Given Pfizer Experimental Duchenne Muscular Dystrophy Therapy Dies
PTC Therapeutics to Participate at Upcoming Investor Conferences
WARREN, N.J., May 2, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences: RBC Capital Markets 2024
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript
Express News | PTC Therapeutics Shares Are Trading Higher After Morgan Stanley Upgraded the Stock From Underweight to Equal-Weight and Raised Its Price Target From $28 to $30
Express News | PTC Therapeutics Inc : Morgan Stanley Raises Target Price to $30 From $28